List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 425 studies with search of: "Hypercholesterolemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Enrolling by invitation An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
2 Active, not recruiting Open Label Extension of ISIS 301012 to Treat Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Intervention: Drug: mipomersen sodium
3 Completed Study to Assess the Safety and Efficacy of ISIS 301012 in Homozygous Familial Hypercholesterolemia
Conditions: Lipid Metabolism, Inborn Errors;   Hypercholesterolemia, Autosomal Dominant;   Hyperlipidemias;   Metabolic Diseases;   Hyperlipoproteinemia Type II;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Infant, Newborn, Diseases;   Metabolic Disorder;   Congenital Abnormalities;   Hypercholesterolemia;   Hyperlipoproteinemias;   Dyslipidemias;   Lipid Metabolism Disorders
Interventions: Drug: mipomersen sodium;   Drug: Placebo
4 Active, not recruiting A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
5 Completed A 12-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)(COMPLETED)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
6 Completed
Has Results 		Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)
Conditions: Primary Hypercholesterolemia;   Homozygous Familial Hypercholesterolemia
Intervention: Drug: Ezetimibe
7 Completed Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MD-0727
8 Active, not recruiting Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Intervention: Drug: Pitavastatin
9 Completed Pan-European Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
10 Not yet recruiting Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Condition: Familial Hypercholesterolemia
Intervention: Drug: lomitapide
11 Completed Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention:
12 Completed Effect of the Plantago Ovata Husk on the Lipid Profile of Patients With Hypercholesterolemia
Conditions: Hypercholesterolemia;   Cardiovascular Disease
Intervention: Drug: Plantago ovata husk
13 Completed An Extension Study of An Investigational Drug in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Drug: MK0653A, ezetimibe (+) simvastatin / Duration of Treatment: 14 weeks
14 Active, not recruiting A Study on the Effects of Soy Protein on Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Soy protein; 25 grams/day;   Dietary Supplement: Control protein
15 Enrolling by invitation STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)
Conditions: Hypertension;   Hypercholesterolemia
Intervention: Other: Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide
16 Completed A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia
Conditions: Essential Hypertension;   Hypercholesterolemia
Interventions: Drug: simvastatin;   Drug: valsartan
17 Terminated Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
18 Completed A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: MK0653A, ezetimibe (+) simvastatin;   Drug: Comparators: simvastatin and ezetimibe
19 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: placebo
20 Terminated Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services